In 30 metastatic NSCLC patients who progressed on PD-1/PD-L1 inhibitors, the triple IO combo regimen at median follow-up time of 11.5 months achieved a DCR of 89.3% and Median PFS of 8.6 months ...
CHENNAI, India, Oct. 8, 2025 /CNW/ -- India's No:1 Ranked Institute, the Indian Institute of Technology Madras, and Danish researchers have shown how interactions between genetic variants can act like ...
A scientific study by IIT-Kanpur, in partnership with the National Mission for Clean Ganga, has revealed the severe geomorphic and ecological damage caused by sand mining. The research highlights the ...
FLORHAM PARK, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company developing innovative cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback